A big move to increase blood donations.
New FDA rules are going to make it possible
for more gay and bisexual men to save lives.
The FDA finalized new risk based rules for blood donations.
These rules are designed to reduce the spread of HIV.
In the past, all men who admitted having sex with men
were effectively banned from donating under the new rules.
Everyone has to add to the same set of
screening questions no matter their gender or orientation.
Gay and bisexual men in monogamous relationships will now be able to donate
the FDA made the change after examining data from countries with similar HIV rates
and countries who have similar risk based blood donation rules in place
drug maker, Eli Lily says it is not raising prices on insulin products.
Eli Lily, together with Novo
Nordisk and Soofi
control more than 90% of the worldwide insulin market.
The CEOS of all three companies were at a senate hearing on Wednesday,
Senator Bernie Sanders chairs the Senate Health Committee and he asked each CEO
to commit to never increase the price of any insulin drug again,
but only Lily's head said yes,
no,
Nordisk and soofi
would only say that they would limit their increases to
single digit Sanders had this to say to the ceos.
And when you go to sleep tonight,
I hope you ask yourselves. Think about the people who died
because they can't afford medicine.
Think about the millions of people even not in the United States
who cannot afford the products that you make that cost you a few bucks.
I for the life of me
just don't understand how when you have something that
saves a life and it cost you a few bucks
to manufacture and you're already making huge amounts of profits.
Why we can't make that product available to all at a price that they can afford?
That is a moral issue.
And he's just one of the people who are criticizing these companies.
All three are facing a lot of pressure to make their drugs more affordable
and other medical news,
a new vaccine could help in the fight against a deadly form of pancreatic cancer.
In a study published in the Journal Nature Us,
research has revealed a new personalized M R N A vaccine had very promising results.
The study found the vaccine prevented cancer from returning in 50% of patients.
Scientists
at Memorial Sloan Kettering Cancer Center in New
York did this research together with German scientists
and the study was very small, just 16 patients. And the vaccine was part of a regime
that also included chemotherapy and another drug.
But one of the doctors behind the research called it, quote, very encouraging.